Researcher ICON Sued by Investor Over Revenue Miss Stock Dive
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...
ICLR SHAREHOLDER ALERT: ICON plc Investors are Notified of Pending Class Action and are Urged to Contact BFA Law
New York, New York-- (Newsfile Corp. - February 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain ...
J.P. Morgan Sticks to Their Buy Rating for Icon (ICLR)
J.P. Morgan analyst Casey Woodring maintained a Buy rating on Icon (ICLR – Research Report) on February 1 and set a price target of $265.00.